vaccines Flashcards

1
Q

father of vaccination

A

edward jenner
- used attenuated strain of cowpox – smallpox vaccine
- cross-reactivity between antibodies generated to cowpox that cross-react to smallpox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

challenge = ___

A

to test the efficacy of the vaccine by infecting individual with the virulent pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

purpose of vaccination

A
  • to induce the generation of long-lived memory T and B cells that protect against subsequent infection, without inducing disease
  • herd immunity (provides protection to most susceptible members of a population)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

purpose of vaccination is to generate ___ pathogen-specific T and B cell memory responses

A

long-lived

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

broad spectrum vaccines require ___, which means…

A

multivalency
carries more than one antigen from the pathogen in the vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

___ promote immune responses to weakly immunogenic substances
mostly though…

A

adjuvants
maturation of DC’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

features of effective vaccines

A

safe
protective, sustained protection
induces neutralizing antibody
induces protective T cells
low cost, few side-effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list the 4 types of vaccines approved for human use

A

1- live attenuated
2- killed
3- acellular
4- polysaccharide conjugate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define live attenuated vaccine

A

attenuated pathogens that exhibit no pathogenicity but induce protective immunity
- ex: influenza virus- flu mist ; BCG- tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define killed vaccine

A

inactivated pathogens that still induce protective immunity
- ex: B. pertussis, polio virus, influenza virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define acellular vaccine

A

recombinant proteins, subunits- have certain subunits of pathogen
- ex: Hepatitis B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

define polysaccharide conjugate vaccine

A

linked protein carrier and polysaccharide
- isolate polysaccharides from bacteria, couple with protein carrier- conjugate
- ex: H. Influenzae, S. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pros and cons of live attenuated vaccines

A

pros:
- strong immune response generating pathogen-specific T and B cells
- long-lived immunity
- single dose required

cons:
- danger of reversion to virulence
- rare reactions
- cannot be used in immunocompromised individual
- may not be stable under all storage conditions
- expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name a more targeted approach to live attenuated vaccines

A

know sequence of the viral genome, focus on genes that cause virulence and mutate/delete them –> immunize patient with attenuated strain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

name pros and cons of killed vaccines

A

pros:
- safe and stable - not possible of reversion

cons:
- multiple doses required
- short lived protection
- limited CD8+ T cell activation
- generally less effective at eliciting protective immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe acellular (subunit) vaccination

A
  • nonpathogenic, easily manipulated, stable
  • requires adjuvant and knowledge of protective antigens
  • requires multiple doses
  • multivalency a requirement for broad protection
17
Q

what is an adjuvant

A
  • agents added to vaccine formulations that enhance the immunogenicity of antigens in vivo
  • 2 types: immunopotentiators and delivery systems
    . immunopotentiators often trigger TLR
    . delivery systems serve to prolong the duration of antigen exposure, “antigen depot”
18
Q

why are adjuvants required in many acellular vaccine formulations

A
  • b/c stimulation of the adaptive immune system without linked activation of the innate response tends to elicit limited immunity
  • b/c recombinant proteins may not fold correctly to induce pathogen-specific antibody responses
  • b/c antigen administered without adjuvant may cause autoimmunity
19
Q

example of an adjuvant

A

Alum
- aluminum salts
- induces DC maturation
. the PRR: NLRP3 targets the inflammasome
. low-level inflammation

20
Q

what is the benefit of polysaccharide-protein conjugate vaccines?

A

conjugate vaccines rely on linked recognition
- B cell binds polysaccharide epitope linked to tetanus toxoid protein
- antigen internalized and processed
- peptides from protein component presented to T cell
- activated B cell produces antibody against polysaccharide antigen on the surface of the bacterium

21
Q

describe recombinant vectors

A

engineered microorganisms that carry genes from infectious agents
- adenovirus- used in HIV vaccine trials
- S. typhimurium

22
Q

recombinant vectors pros and cons

A

pros:
- single dose
- induced cell-mediated responses

cons:
- possibility of reversion
- vaccine complications

23
Q

name 3 types of experimental vaccines

A

1- cell-based: been used with cancers, grow patients DC’s in culture, load with antigens of choice, re-administer to patient - prime T cells to recognize tumor antigens

2- DNA: encodes protein antigens

3- viral or bacterial vectors: microorganisms that carry heterologous antigens

24
Q

challenges for vaccine development

A
  • most vaccines elicit strong antibody responses
    . circulating neutralizing antibodies prevents systemic spread of pathogens
  • but few elicit good CD8+ CTL responses
25
Q

how does a vaccine become approved for use in humans?

A

pre-clinical phase - in animals
phase 1 - safety testing, side effects measured in people
phase 2- more people given, “proof of concept phase”
phase 3- large scale administration, safe to FDA